HOME Top Market Reports Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021

Infection Surveillance Solutions Market by Product (Software (On Premise, Web Based), Services (Training & Consulting, Implementation)), End User (Hospitals, LTCs, Nursing Home, Skilled Nursing Facility, Assisted Living) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: June 2016
Report Code: HIT 4380

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global infection surveillance solutions market is projected to reach USD 508.8 Million by 2021, at a CAGR of 14.1% from 2016 to 2021. The market has witnessed substantial growth in the past few years driven by the increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditure, and increasing number of surgeries. However, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare tools, and dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of the market to a certain extent.

Geographically, the infection surveillance solutions market in North America and Europe accounted for large market shares owing to the increasing incidence of HAIs, government policies for preventing HAIs, rising healthcare expenditure in these regions. The Asia-Pacific region, especially Japan, China, and India, is expected to register highest growth owing to the rising incidences of HAIs, increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, and rapid improvement in the health insurance sector in these countries.

In order to maintain their market shares, major players focus on new product launches, product enhancements expansions, partnerships, agreements, and collaborations and acquisitions as key growth strategies. Of all these strategies, partnerships, agreements, and collaborations were the key strategies adopted by the major market players in the period of 2012 to 2016.

On the basis of product, the market is segmented into software and services. The software segment held the largest share of the market in 2015, primarily due to higher adoption of infection surveillance software by healthcare facilities. Hospitals are the largest end users of infection surveillance solutions, followed by long-term care facilities.

Some of the prominent players in the global infection surveillance solutions market are Becton, Dickinson and Company (U.S.), Premier Inc. (U.S.), Wolters Kluwer N.V. (Netherlands,), Baxter International Inc. (U.S.), GOJO Industries, Inc. (U.S.), Atlas Medical Software (U.S.), Deb Group Ltd (U.K.), Hygreen Inc. (U.S.), RL Solutions (Canada), and TRUVEN Health Analytics (U.S.).

Target Audience

  • Infection surveillance software providers
  • Infection control practitioner
  • Hospitals and LTC facilities
  • Various research and consulting firms
  • Distributors of infection surveillance software
  • Healthcare institutions
  • Research institutes
  • Venture capitalists and investors

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

Infection surveillance is the ongoing systematic collection, analysis, and interpretation of healthcare-associated infections (HAIs) data essential for planning, implementation, and evaluation of public health practices, especially to curtail the rapid increase of nosocomial infections, such as central line-associated bloodstream infection (CLABSI), surgical site infection (SSI), ventilator-associated pneumonia (VAP), and catheter-associated urinary tract infection (CAUTI) in healthcare facilities.

Infection Surveillance Solutions Market

This research report categorizes the infection surveillance solutions market into the following segments:

  • Global Infection Surveillance Solutions Market, by Product
    • Software
      • On-premise
      • Web-based
    • Services
      • Product Support & Maintenance Services
      • Training & Consulting Services
      • Implementation Services
  • Global Infection Surveillance Solutions Market, by End User
    • Hospitals
      • Large Hospitals
      • Medium-sized Hospitals
      • Small Hospitals
    • Long-term Care Facilities
      • Homecare Agencies & Hospices
      • Nursing Homes
      • Assisted Living Facilities
    • Other End Users (primarily includes ambulatory care centers and academic institutes)
  • Global Infection Surveillance Solutions Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia-Pacific (APAC)
      • China
      • Japan
      • India
      • Rest of APAC
    • Rest of the World (RoW)
      • Latin America
      • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific infection surveillance solutions market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Latin American infection surveillance solutions market into Brazil, Argentina, and the Rest of Latin America

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Approach
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Secondary Sources
           2.4.1 Key Data From Secondary Sources
    2.5 Primary Sources
           2.5.1 Key Data From Primary Sources
           2.5.2 Key Industry Insights From Primary Sources
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 34)
    4.1 Infection Surveillance Solutions Market Overview
    4.2 North America: Infection Surveillance Solutions Market, By Product
    4.3 Geographic Snapshot: Infection Surveillance Solutions Market
    4.4 North America to Dominate the Market During the Forecast Period
    4.5 Infection Surveillance Solutions Market: Developing vs Developed Countries

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Infection Surveillance Solutions Market Segmentation
           5.2.1 By Products & Services
           5.2.2 By End User
    5.3 Market Dynamics
           5.3.1 Infection Surveillance Solutions Market Drivers
                    5.3.1.1 Increasing Incidence of Hais
                    5.3.1.2 Government Policies for Preventing Hais
                    5.3.1.3 Increasing Healthcare Expenditure
                    5.3.1.4 Increasing Number of Surgeries
           5.3.2 Infection Surveillance Solutions Market Restraints
                    5.3.2.1 High Cost of Software
                    5.3.2.2 Reluctance Among Medical Professionals to Adopt Advanced Healthcare Tools
                    5.3.2.3 Dearth of Skilled It Professionals in the Healthcare Industry
           5.3.3 Market Opportunities
                    5.3.3.1 Cloud-Based Software Offers Significant Growth Opportunities
                    5.3.3.2 High Growth in Developing Counties Across APAC and Latin America
           5.3.4 Market Challenges
                    5.3.4.1 Under Developed It Infrastructure in Developing Countries
    5.4 Industry Trends
           5.4.1 Shift Towards Automation in Healthcare Facilities
           5.4.2 Growing Demand for Web-Based Solutions and Mobile Platforms
    5.5 Key Buying Criteria

6 Global Infection Surveillance Solutions Market, By Product (Page No. - 52)
    6.1 Introduction
    6.2 Software
           6.2.1 On-Premise Software
           6.2.2 Web-Based Software
    6.3 Services
           6.3.1 Product Support & Maintenance Services
           6.3.2 Training & Consulting Services
           6.3.3 Implementation Services

7 Global Infection Surveillance Solutions Market, By End User (Page No. - 63)
    7.1 Introduction
    7.2 Hospitals
           7.2.1 Large Hospitals
           7.2.2 Medium-Sized Hospitals
           7.2.3 Small Hospitals
    7.3 Long-Term Care Facilities
           7.3.1 Nursing Homes
           7.3.2 Skilled Nursing Facilities
           7.3.3 Assisted Living Facilities
    7.4 Other End Users

8 Global Infection Surveillance Solutions Market, By Region (Page No. - 76)
    8.1 Introduction
    8.2 North America
           8.2.1 U.S.
           8.2.2 Canada
    8.3 Europe
           8.3.1 Germany
           8.3.2 France
           8.3.3 U.K.
           8.3.4 Italy
           8.3.5 Spain
           8.3.6 Rest of Europe
    8.4 Asia-Pacific
           8.4.1 Japan
           8.4.2 China
           8.4.3 India
           8.4.4 Rest of Asia-Pacific
    8.5 Rest of the World
           8.5.1 Latin America
           8.5.2 Middle East and Africa

9 Competitive Landscape (Page No. - 156)
    9.1 Overview
    9.2 Leading Players in the Market
    9.3 Competitive Situation and Trends
           9.3.1 Partnerships, Agreements, and Collaborations
           9.3.2 Product Enhancements
           9.3.3 Acquisitions
           9.3.4 New Product Launches
           9.3.5 Expansions

10 Company Profiles (Page No. - 165)
(Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*
     10.1 Introduction
     10.2 Becton, Dikinson and Company
     10.3 Premier Inc.
     10.4 Wolters Kluwer N.V.
     10.5 Baxter International Inc.
     10.6 Gojo Industries, Inc.
     10.7 RL Solutions
     10.8 Truven Health Analytics (An IBM Company)
     10.9 DEB Group Ltd.
     10.10 Hygreen, Inc.
     10.11 Atlas Medical Software

*Details on Company Financial Might Not Be Captured in Case of Unlisted Companies

11 Appendix (Page No. - 185)
     11.1 Insights of Industry Experts
     11.2 Discussion Guide
     11.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     11.4 Introducing RT: Real-Time Market Intelligence
     11.5 Available Customizations
     11.6 Related Reports


List of Tables (154 Tables)

Table 1 Infection Surveillance Solutions Market Snapshot, 2016 vs 2021
Table 2 Principal Operative Procedures With High Risk of Ssis
Table 3 Global Infection Surveillance Solutions Market Size, By Product, 2014-2021 (USD Million)
Table 4 Global Infection Surveillance Software Market Size, By Type, 2014-2021 (USD Million)
Table 5 Global Infection Surveillance Software Market Size, By Country/Region, 2014-2021 (USD Million)
Table 6 Global On-Premise Infection Surveillance Software Market Size, By Country/Region, 2014-2021 (USD Million)
Table 7 Global Web-Based Infection Surveillance Software Market Size, By Country/Region, 2014-2021 (USD Million)
Table 8 Global Infection Surveillance Services Market Size, By Type, 2014-2021 (USD Million)
Table 9 Global Infection Surveillance Services Market Size, By Country/Region, 2014-2021 (USD Million)
Table 10 Global Product Support & Maintenance Services Market Size, By Country/Region, 2014-2021 (USD Million)
Table 11 Global Training and Consulting Services Market Size, By Country/Region, 2014-2021 (USD Million)
Table 12 Global Implementation Services Market Size, By Country/Region, 2014-2021 (USD Million)
Table 13 Global Infection Surveillance Solutions Market Size, By End User, 2014–2021 (USD Million)
Table 14 Global Infection Surveillance Solutions Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 15 Global Infection Surveillance Solutions Market Size for Hospitals, By Country/Region, 2014–2021 (USD Million)
Table 16 Global Infection Surveillance Solutions Market Size for Large Hospitals, By Country/Region, 2014–2021 (USD Million)
Table 17 Global Infection Surveillance Solutions Market Size for Medium-Sized Hospitals, By Country/Region, 2014–2021 (USD Million)
Table 18 Global Infection Surveillance Solutions Market Size for Small Hospitals, By Country/Region, 2014–2021 (USD Million)
Table 19 Global Infection Surveillance Solutions Market Size for Long-Term Care Facilities, By Type, 2014–2021(USD Million)
Table 20 Global Infection Surveillance Solutions Market Size for Long-Term Care Facilities, By Country/Region, 2013–2020 (USD Million)
Table 21 Global Infection Surveillance Solutions Market Size for Nursing Homes, By Country/Region, 2014–2021 (USD Million)
Table 22 Global Infection Surveillance Solutions Market Size for Skilled Nursing Facilities, By Country/Region, 2014–2021 (USD Million)
Table 23 Global Market Size for Assisted Living Facilities, By Country/Region, 2014–2021 (USD Million)
Table 24 Global Market Size for Other End Users, By Country/Region, 2014–2021 (USD Million)
Table 25 Global: Market Size, By Region, 2014–2021 (USD Million)
Table 26 North America: Market Size, By Country, 2014–2021 (USD Million
Table 27 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 28 North America: Market Size, By Software Type, 2014–2021 (USD Million)
Table 29 North America: Market Size, By Service Type, 2014–2021 (USD Million)
Table 30 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 31 North America: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 32 North America: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 33 U.S.: Market Indicators
Table 34 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 35 U.S.: Market Size, By Software Type, 2014–2021 (USD Million)
Table 36 U.S.: Market Size, By Services Type, 2014–2021 (USD Million)
Table 37 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 38 U.S.: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 39 U.S.: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 40 Canada: Market Indicators
Table 41 Canada.: Market Size, By Product, 2014–2021 (USD Million)
Table 42 Canada: Market Size, By Software Type, 2014–2021 (USD Million)
Table 43 Canada: Market Size, By Services Type, 2014–2021 (USD Million)
Table 44 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 45 Canada: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 46 Canada: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 47 Europe: Market Size, By Country, 2014–2021 (USD Million
Table 48 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 49 Europe: Market Size, By Software Type, 2014–2021 (USD Million)
Table 50 Europe: Market Size, By Services Type, 2014–2021 (USD Million)
Table 51 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 52 Europe: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 53 Europe: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 54 Germany: Market Indicators
Table 55 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table 56 Germany: Market Size, By Software Type, 2014–2021 (USD Million)
Table 57 Germany: Market Size, By Services Type, 2014–2021 (USD Million)
Table 58 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 59 Germany: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 60 Germany: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 61 France: Market Indicators
Table 62 France: Market Size, By Product, 2014–2021 (USD Million)
Table 63 France: Market Size, By Software Type, 2014–2021 (USD Million)
Table 64 France: Market Size, By Services Type, 2014–2021 (USD Million)
Table 65 France: Market Size, By End User, 2014–2021 (USD Million)
Table 66 France: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 67 France: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 68 U.K.: Market Indicators
Table 69 U.K.: Market Size, By Product, 2014–2021 (USD Million)
Table 70 U.K.: Market Size, By Software Type, 2014–2021 (USD Million)
Table 71 U.K.: Market Size, By Services Type, 2014–2021 (USD Million)
Table 72 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 73 U.K.: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 74 U.K.: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 75 Italy: Market Indicators
Table 76 Italy: Market Size, By Product, 2014–2021 (USD Million)
Table 77 Italy: Market Size, By Software Type, 2014–2021 (USD Million)
Table 78 Italy: Market Size, By Services Type, 2014–2021 (USD Million)
Table 79 Italy: Market Size, By End User, 2014–2021 (USD Million)
Table 80 Italy: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 81 Italy: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 82 Spain: Market Indicators
Table 83 Spain: Market Size, By Product, 2014–2021 (USD Million)
Table 84 Spain: Market Size, By Software Type, 2014–2021 (USD Million)
Table 85 Spain: Market Size, By Services Type, 2014–2021 (USD Million)
Table 86 Spain: Market Size, By End User, 2014–2021 (USD Million)
Table 87 Spain: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 88 Spain: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 89 RoE: Market Size, By Product, 2014–2021 (USD Million)
Table 90 RoE: Market Size, By Software Type, 2014–2021 (USD Million)
Table 91 RoE: Market Size, By Services Type, 2014–2021 (USD Million)
Table 92 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 93 RoE: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 94 RoE: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 95 APAC: Market Size, By Country, 2014–2021 (USD Million)
Table 96 APAC: Market Size, By Product, 2014–2021 (USD Million)
Table 97 APAC: Market Size, By Software Type, 2014–2021 (USD Million)
Table 98 APAC: Market Size, By Services Type, 2014–2021 (USD Million)
Table 99 APAC: Market Size, By End User, 2014–2021 (USD Million)
Table 100 APAC: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 101 APAC: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 102 Japan: Market Indicators
Table 103 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 104 Japan: Market Size, By Software Type, 2014–2021 (USD Million)
Table 105 Japan: Market Size, By Services Type, 2014–2021 (USD Million)
Table 106 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 107 Japan: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 108 Japan: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 109 China: Market Indicators
Table 110 China: Market Size, By Product, 2014–2021 (USD Million)
Table 111 China: Market Size, By Software Type, 2014–2021 (USD Million)
Table 112 China: Market Size, By Services Type, 2014–2021 (USD Million)
Table 113 China: Market Size, By End User, 2014–2021 (USD Million)
Table 114 China: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 115 China: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 116 India: Market Indicators
Table 117 India: Market Size, By Product, 2014–2021 (USD Million)
Table 118 India: Market Size, By Software Type, 2014–2021 (USD Million)
Table 119 India: Market Size, By Services Type, 2014–2021 (USD Million)
Table 120 India: Market Size, By End User, 2014–2021 (USD Million)
Table 121 India: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 122 India: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 123 RoAPAC: Market Size, By Product, 2014–2021 (USD Million)
Table 124 RoAPAC: Market Size, By Software Type, 2014–2021 (USD Million)
Table 125 RoAPAC: Market Size, By Services Type, 2014–2021 (USD Million)
Table 126 RoAPAC: Market Size, By End User, 2014–2021 (USD Million)
Table 127 RoAPAC: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 128 RoAPAC: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 129 RoW: Market Size, By Region, 2014–2021 (USD Million)
Table 130 RoW: Market Size, By Product, 2014–2021 (USD Million)
Table 131 RoW: Market Size, By Software Type, 2014–2021 (USD Million)
Table 132 RoW: Market Size, By Services Type, 2014–2021 (USD Million)
Table 133 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 134 RoW: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 135 RoW: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 136 Latin America: Market Size, By Product, 2014–2021 (USD Million)
Table 137 Latin America: Market Size, By Software Type, 2014–2021 (USD Million)
Table 138 Latin America: Market Size, By Services Type, 2014–2021 (USD Million)
Table 139 Latin America: Market Size, By End User, 2014–2021 (USD Million)
Table 140 Latin America: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 141 Latin America: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 142 Middle East and Africa: Market Size, By Product, 2014–2021 (USD Million)
Table 143 Middle East and Africa: Market Size, By Software Type, 2014–2021 (USD Million)
Table 144 Middle East and Africa: Market Size, By Services Type, 2014–2021 (USD Million)
Table 145 Middle East and Africa: Market Size, By End User, 2014–2021 (USD Million)
Table 146 Middle East and Africa: Market Size for Hospitals, By Type, 2014–2021 (USD Million)
Table 147 Middle East and Africa: Market Size for Long-Term Care Facilities, By Type, 2014–2021 (USD Million)
Table 148 Key Players in the Global Infection Surveillance Solutions Market
Table 149 Growth Strategy Matrix (2012–2016)
Table 150 Partnerships, Agreements, and Collaborations, 2013–2015
Table 151 Product Enhancements, 2012–2015
Table 152 Acquisitions, 2014–2016
Table 153 New Product Launches, 2013–2015
Table 154 Expansions, 2013–2015


List of Figures (62 Figures)

Figure 1 Infection Surveillance Solutions Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 7 Infection Surveillance Solutions Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 8 Infection Surveillance Software Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 9 Infection Surveillance Services Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 10 Infection Surveillance Solutions Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 11 Global Infection Surveillance Solutions Market Size for Hospitals, By Type, 2016 vs 2021 (USD Million)
Figure 12 Global Infection Surveillance Solutions Market for Long-Term Care Facilities, By Type, 2016 vs 2021 (USD Million)
Figure 13 Geographic Analysis: Global Infection Surveillance Solutions Market
Figure 14 Increasing Incidence of Healthcare-Associated Infections to Drive Market Growth During the Forecast Period
Figure 15 U.S. Held the Largest Share of the North American Infection Surveillance Solutions Market in 2015
Figure 16 China & Japan Provide High Growth Potential for Infection Surveillance Solutions Market
Figure 17 Infection Surveillance Solutions Market: Geographic Mix
Figure 18 China to Register the Highest Growth During the Forecast Period
Figure 19 Infection Surveillance Solutions Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Common Healthcare-Associated Infections in the U.S. Acute Care Hospitals
Figure 21 Global Healthcare Expenditure, 2003-2013
Figure 22 Healthcare Expenditure Growth Rate Across Key Geographies
Figure 23 Key Industry Trends
Figure 24 Global Infection Surveillance Solutions Market, By Product, 2016 vs 2021 (USD Million)
Figure 25 Global Infection Surveillance Software Market, By Type, 2016 vs 2021 (USD Million)
Figure 26 Global Infection Surveillance Services Market, By Type, 2016 vs 2021 (USD Million)
Figure 27 Global Infection Surveillance Solutions Market, By End User, 2016 vs 2021 (USD Million)
Figure 28 Global Infection Surveillance Solutions Market for Hospitals, By Type, 2016 vs 2021 (USD Million)
Figure 29 Global Infection Surveillance Solutions Market for Long-Term Care Facilities, By Type, 2016 vs 2021 (USD Million)
Figure 30 Geographic Snapshot (2016-2021): Asia-Pacific, an Emerging Growth Hotspot
Figure 31 North American Infection Surveillance Solutions Market Snapshot, 2016
Figure 32 North America: Healthcare Expenditure, 2003-2013
Figure 33 U.S.: Distribution of Common Healthcare-Associated Infections, 2012
Figure 34 U.S.: Healthcare Expenditure, 2003-2013
Figure 35 Canada: Healthcare Expenditure, 2003-2013
Figure 36 Europe: Healthcare Expenditure, 2003-2013
Figure 37 Germany: Distribution of Common Healthcare-Associated Infections, 2012
Figure 38 Germany: Healthcare Expenditure, 2003-2013
Figure 39 France: Distribution of Common Healthcare-Associated Infections, 2012
Figure 40 France: Healthcare Expenditure, 2003-2013
Figure 41 U.K.: Distribution of Common Healthcare-Associated Infections, 2012
Figure 42 U.K.: Healthcare Expenditure, 2003-2013
Figure 43 Italy: Distribution of Common Healthcare-Associated Infections, 2012
Figure 44 Italy: Healthcare Expenditure, 2003-2013
Figure 45 Spain: Distribution of Common Healthcare-Associated Infections, 2012
Figure 46 Spain: Healthcare Expenditure, 2003-2013
Figure 47 RoE: Healthcare Expenditure, 2003-2013
Figure 48 Asia-Pacific Infection Surveillance Solutions Market Snapshot, 2016
Figure 49 APAC: Healthcare Expenditure, 2003-2013
Figure 50 Japan: Healthcare Expenditure, 2003-2013
Figure 51 China: Healthcare Expenditure, 2003-2013
Figure 52 India: Healthcare Expenditure, 2003-2013
Figure 53 RoAPAC: Healthcare Expenditure, 2003-2013
Figure 54 Latin America: Healthcare Expenditure, 2003-2013
Figure 55 Middle East and Africa: Healthcare Expenditure, 2003-2013
Figure 56 Partnerships, Agreements, and Collaborations Were the Key Growth Strategies Adopted By Market Players (2012–2016)
Figure 57 Key Growth Strategies Adopted By Market Players (2012–2016)
Figure 58 Geographic Revenue Mix of the Top Four Players
Figure 59 Company Snapshot: Becton, Dikinson and Company
Figure 60 Company Snapshot: Premier Inc.
Figure 61 Company Snapshot: Wolters Kluwer N.V.
Figure 62 Company Snapshot: Baxter International Inc.

The global infection surveillance solutions market is estimated to reach USD 508.8 Million by 2021, at a CAGR of 14.1% during the forecast period. The market is primarily driven by the increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditures, and increasing number of surgeries. On the other hand, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare tools, and dearth of skilled IT professionals in the healthcare industry are some factors that are expected to limit the growth of the market in the coming years.

The global infection surveillance solutions market is segmented on the basis of product, end user, and region.

On the basis of products, the market is classified into software and services. The software segment is further segmented into on-premise and web-based software. The services included in this report are subdivided into product support & maintenance, training & consulting, and implementation services. By end user, the market is segmented into hospitals and long-term care facilities. Hospitals are further sub-divided on the basis of bed size into large, medium-sized, and small hospitals. Long-term care facilities included in this report are nursing homes, skilled nursing facilities, and assisted living facilities.

The global infection surveillance solutions market is further divided into four major regions North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. North America accounted for the largest regional market in 2015, followed by Europe. North America and Europe are expected to witness a healthy growth rate in the coming years, owing to the increasing incidence of HAIs, government policies for preventing HAIs, and rising healthcare expenditures.

Infection Surveillance Solutions Market

The Asia-Pacific region, on the other hand, represents the fastest-growing market for infection surveillance solutions. The high growth rate in this market is primarily attributed to the rising incidences of HAIs, increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, and rapid improvements in the health insurance sector in the APAC countries.

This research report discusses the key market drivers, restraints, challenges, and opportunities in the global market and its submarkets. The leading players in the global infection surveillance solutions market include Becton, Dickinson and Company (U.S.), Premier Inc. (U.S.), Wolters Kluwer N.V. (Netherlands,), Baxter International Inc. (U.S.), and GOJO Industries, Inc. (U.S.). Other players in this market are Atlas Medical Software (U.S.), Deb Group Ltd (U.K.), Hygreen Inc. (U.S.), RL Solutions (Canada), and TRUVEN Health Analytics (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Healthcare IT Markets on KnowledgeStore
Request Demo